During the past decade, Hopital de la Cavale Blanche conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 15 clinical trials were completed, i.e. on average, 17.9% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 10 clinical trials were completed. i.e. 23.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital de la Cavale Blanche" #1 sponsor was "Assistance Publique - Hôpitaux de Paris" with 8 trials, followed by "University Hospital, Brest" with 8 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored, "Ipsen" with 4 trials sponsored and "Nantes University Hospital" with 4 trials sponsored. Other sponsors include 105 different institutions and companies that sponsored additional 86 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital de la Cavale Blanche" #1 collaborator was "Ministry of Health, France" with 7 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials as a collaborator, "University Hospital, Tours" with 3 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Hopital de la Cavale Blanche" are "Rheumatoid Arthritis" (6 trials), "Heart Failure" (5 trials), "Idiopathic Pulmonary Fibrosis" (5 trials), "Coronary Artery Disease" (4 trials) and "Pulmonary Hypertension" (4 trials). Many other conditions were trialed in "Hopital de la Cavale Blanche" in a lesser frequency.

Most popular intervention types in "Hopital de la Cavale Blanche" are "Drug" (63 trials), "Device" (28 trials), "Other" (24 trials), "Procedure" (13 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "placebo" (3 trials), "Baricitinib" (2 trials), "Masitinib" (2 trials) and "PRM-151 (Zinpentraxin Alfa)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopital de la Cavale Blanche" are 134 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 35 active trials in "Hopital de la Cavale Blanche". 5 are not yet recruiting, 22 are recruiting, 6 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 77 completed trials in Hopital de la Cavale Blanche, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital de la Cavale Blanche, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 32 trials that are defined as “Not Applicable".